powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1306059019
Christopher Lippincott
M.D.
Infectious Disease
Baltimore,
MD
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
QUALITY · MIPS · 2024
Final MIPS score
83.3
Quality
73.9
Cost
70.5
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.35%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (3)
CCN 090005
Hospital
CCN 210009
Hospital
CCN 210029
Hospital
PRESCRIBING · PART D · 2024
Total Rx claims
438
Beneficiaries
—
Total drug cost
$1.4M
Distinct drugs
17
Brand share
57.3%
Top prescribed drugs
Ethambutol Hcl
66 claims
Bictegrav/Emtricit/Tenofov Ala
43 claims
Azithromycin
40 claims
Amikacin Liposomal/Neb.Accessr
38 claims
Amoxicillin/Potassium Clav
28 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
541
Unique beneficiaries
—
Total services
771
Distinct HCPCS
11
Medicare payment
$54K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 187 Infectious Disease providers in MD — top quintile (cohort median 277).
